India to Brazil: Amphotericin Export Trade Route
India has recorded 21 verified shipments of Amphotericin exported to Brazil, representing a combined trade value of $3.8M USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $182.2K USD. The leading Indian exporter is BHARAT SERUMS AND VACCINES LIMITED, which accounts for 72% of total export value with 3 shipments worth $2.8M USD. On the buying side, MINISTERIO DA SAUDE/DEPARTAMENTO DE is the largest importer in Brazil with $2.8M USD in purchases. The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, BHARAT SERUMS AND VACCINES LIMITED , CIPLA LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Amphotericin corridor is one of India's established pharmaceutical export routes, with 21 shipments documented worth a combined $3.8M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's amphotericin manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $182.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with amphotericin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 21.6%, placing it at rank #8 among India's top amphotericin export destinations globally.
On the import side, key buyers of Indian amphotericin in Brazil include MINISTERIO DA SAUDE/DEPARTAMENTO DE, MINISTERIO DA SAUDE/DEPARTAMEN , CIPLA BRASIL IMPORTADORA E DISTRIB and 7 others. MINISTERIO DA SAUDE/DEPARTAMENTO DE is the single largest importer with 3 shipments valued at $2.8M USD.
